"Immutep will apply the non-dilutive funding towards furthering its current active clinical trial programs for its lead product candidate, efti. The expected cash reach of the Company extends into early calendar year 2026."
- Forums
- ASX - By Stock
- IMM
- Ann: Immutep receives Australian R&D Tax Incentive
Ann: Immutep receives Australian R&D Tax Incentive, page-2
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.5¢ |
Change
0.005(1.47%) |
Mkt cap ! $501.1M |
Open | High | Low | Value | Volume |
33.5¢ | 34.8¢ | 33.5¢ | $932.8K | 2.725M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29411 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 938315 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1434 | 0.370 |
1 | 24200 | 0.345 |
5 | 96552 | 0.340 |
7 | 240185 | 0.335 |
20 | 299931 | 0.330 |
Price($) | Vol. | No. |
---|---|---|
0.330 | 13948 | 3 |
0.335 | 3000 | 1 |
0.340 | 250000 | 1 |
0.350 | 604651 | 5 |
0.355 | 39000 | 2 |
Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |